Session Details

[O7]Oral Presentations 7

Wed. Mar 4, 2026 10:10 AM - 11:40 AM JST
Wed. Mar 4, 2026 1:10 AM - 2:40 AM UTC
Kobe Portopia Hotel(South Wing 1F Ohwada)
【R&D III】

[O7-01]A multi-faceted role of nuclear protein KERP2 in the enteric parasite Entamoeba histolytica: regulation of gene expression and host cell responses

Ruofan Peng1, Herbert J Santos1, *Tomo Nozaki1 (1. Graduate School of Medicine, The University of Tokyo (Japan))
Comment()

[O7-02]Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization

*Yasuo Yoshioka1,2,3,4,5 (1. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 2. Research Institute for Microbial Disease, The University of Osaka (Japan), 3. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. The Research Foundation for Microbial Diseases of Osaka University (Japan))
Comment()

[O7-03]Proteomic landscape of human immune cell subsets

*Koshi Imami1, Rintaro Fujimoto1,2,3, Akari Suzuki1, Jun Seita1, Yukinori Okada1,2,3, Kazuhiko Yamamoto1 (1. RIKEN IMS (Japan), 2. Department of Statistical Genetics, Osaka University Graduate School of Medicine (Japan), 3. Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo (Japan))
Comment()

[O7-04]Exploring Neonatal T Cells: Recent Findings and Insights for Vaccine Development

*Motoko Y. Kimura1, Yuta Iijima1 (1. Graduate School of Medicine, Chiba University (Japan))
Comment()

[O7-05]Identification of T cell epitopes using peptide-MHC-CAR reporter

*Masako Kohyama1,2, Emi Inoue1,2, Daiki Mori1, Wataru Ise1,2 (1. Center for Infectious Disease Education and Research, The University of Osaka (Japan), 2. CAMaD, The University of Osaka (Japan))
Comment()

[O7-06]Vaccine candidates against influenza D virus infection

*Taisuke Horimoto1, Misa Katayama1, Yiyu Xu1, Wataru Sekine1, Shin Murakami1 (1. Graduate School of Agricultural and Life Sciences, The University of Tokyo (Japan))
Comment()

[O7-07]Development and Current Progress of an Integrated Pediatric–Adult, Host–Pathogen Cohort for Infectious Disease Emergencies and the Next Pandemic

*Ho Namkoong1 (1. Department of Infectious Diseases, Keio University School of Medicine (Japan))
Comment()

[O7-08]A Systems Biology Framework for Understanding Antigen Presentation

Anton Kratz1, Micheal Pillay1, Keiko Matsuura1, Kaïdre Bendjama2,1, *Sebastian Kapell2,1 (1. Department of Vaccine Informatics, Institute of Tropical Medicine (Japan), 2. NEC Oncoimmunity AS (Norway))
Comment()

[O7-09]Development of Live Vaccine and Antibody Therapeutics Targeting Henipaviruses

*Makoto Takeda1, Yuying Wang1, Taishi Onodera2, Yuki Kitai1, Yukiko Akahori1, Yang Hekai1, Hiroshi Katoh1, Akihide Ryo2, Katsumi Maenaka3, Takao Hashiguchi4, Junki Maruyama5, Yoshimasa Takahashi2 (1. The UTOPIA Center, The University of Tokyo (Japan), 2. National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 3. Hokkaido University (Japan), 4. Kyoto University (Japan), 5. University of Texas Medical Branch (USA))
Comment()